These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
97 related items for PubMed ID: 2392135
1. Mandatory monitoring for side effects. The "bundling" of clozapine. Salzman C. N Engl J Med; 1990 Sep 20; 323(12):827-9. PubMed ID: 2392135 [No Abstract] [Full Text] [Related]
2. FDA's position on the clozaril patient management system. Peck CC. Hosp Community Psychiatry; 1990 Aug 20; 41(8):876-7. PubMed ID: 2401475 [No Abstract] [Full Text] [Related]
3. FDA approves clozapine for treatment of schizophrenia; careful monitoring required. Hosp Community Psychiatry; 1989 Dec 20; 40(12):1310. PubMed ID: 2591894 [No Abstract] [Full Text] [Related]
5. [Frequent cases of agranulocytosis due to clozapin (leponex) in eastern Switzerland]. Jungi WF, Fischer J, Senn HJ, Hartlapp J, Pöldinger W, Kunz H, Krupp P. Schweiz Med Wochenschr; 1977 Dec 10; 107(49):1861-4. PubMed ID: 929152 [Abstract] [Full Text] [Related]
6. Notes from a state mental health directors' meeting on clozapine. Salzman C. Hosp Community Psychiatry; 1990 Aug 10; 41(8):838-9, 842. PubMed ID: 2401474 [No Abstract] [Full Text] [Related]
8. Clozapine and agranulocytosis. Senn HJ, Jungi WF, Kunz H, Pöldinger W. Lancet; 1977 Mar 05; 1(8010):547. PubMed ID: 65644 [No Abstract] [Full Text] [Related]
9. [Acute bone marrow and liver damage during treatment with clozapine]. Brodowski L, Matusewicz W, Urbańska-Ryś H, Krykowski E. Pol Tyg Lek; 1984 May 21; 39(21):721-2. PubMed ID: 6483677 [No Abstract] [Full Text] [Related]
10. Clozapine and the mandatory monitoring system. N Engl J Med; 1991 Feb 14; 324(7):490-1. PubMed ID: 1988837 [No Abstract] [Full Text] [Related]
11. Sandoz pressured to make drug accessible. Tokarski C. Mod Healthc; 1990 Sep 17; 20(37):39. PubMed ID: 10106200 [No Abstract] [Full Text] [Related]
12. [Clozapine and agranulocytosis]. Xu SH. Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Oct 17; 17(5):271-2. PubMed ID: 6537285 [No Abstract] [Full Text] [Related]
13. Clozapine-induced agranulocytosis: non-cross-reactivity with other psychotropic drugs. Lieberman JA, Johns CA, Kane JM, Rai K, Pisciotta AV, Saltz BL, Howard A. J Clin Psychiatry; 1988 Jul 17; 49(7):271-7. PubMed ID: 3391979 [Abstract] [Full Text] [Related]
15. [Hematologic effects of clozapine: evaluation of the international experience]. Lamarque V. Encephale; 1995 Jun 17; 21 Spec No 3():59-60. PubMed ID: 7628344 [Abstract] [Full Text] [Related]
17. Clozapine for schizophrenia. Med Lett Drugs Ther; 1990 Jan 12; 32(809):3-4. PubMed ID: 2403629 [No Abstract] [Full Text] [Related]
18. [Hematological complications caused by clozapine (Leponex)]. Palva I. Duodecim; 1976 Jan 12; 92(1):1-2. PubMed ID: 1248428 [No Abstract] [Full Text] [Related]
19. Proceedings: The relation between the clinical effect of clozapine and the incidence of side effects. Marecek P, Dolezalová V, Faltus F. Act Nerv Super (Praha); 1975 Jan 12; 17(4):221-2. PubMed ID: 1221762 [No Abstract] [Full Text] [Related]
20. Clozapine-induced agranulocytosis. Incidence and risk factors in the United States. Alvir JM, Lieberman JA, Safferman AZ, Schwimmer JL, Schaaf JA. N Engl J Med; 1993 Jul 15; 329(3):162-7. PubMed ID: 8515788 [Abstract] [Full Text] [Related] Page: [Next] [New Search]